combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology TrimRX | GLP-1 vs. Other
Description
Exenatide (Byetta and Bydureon, AstraZeneca), is a synthetic 39-amino acid peptide (first discovered as exendin-4 in the saliva of the gila monster, Heloderma suspectum) (Figure 8) [879]
doi: 10.1056/NEJMoa2032183
Rahemi H, Nigam N, Wakeling JM
The potent and reliable metabolic effects, coupled with ease of administration, make Ozempic the leading GLP-1 product globally, capturing the largest market share
